Emergent BioSolutions Inc (NYSE: EBS) stock enjoyed a major increase of 12.0% on 5/31/24. The shares closed at $5.70. However, this advance was accompanied by exceptionally low trading volume at 45% of normal. Relative to the market the stock has been strong over the last nine months and has risen 13.5% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, EBS is expected to be a major Value Builder.
Emergent BioSolutions has a current Value Trend Rating of B (Positive). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Emergent BioSolutions has a neutral Power Rating of 53 but a good Appreciation Score of 72, with the Positive Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of B. This review will be completed in the next several days.
Be the first to comment